Saturday, June 16, 2018 1:05:43 PM
1. The 510(k) that Arrayit is most likely currently working on is IMO the allergy test, not OvaDx.
2. OvaDx IP and its fate is, as far as we know, still in Avant's hands. And a few years back they changed the strategy to pursue a 510(k) to compete with CA125 test for monitoring instead of PMA for screening. There has been no announcements saying that the IP has reverted back to Arrayit. And Avant has been silent about Ovadx for a long time and is not even mentioning OvaDx on their website anymore.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM